Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Angelucci

Showing results (21-30 of 96) with videos related to

Pageof 10
Sort By:
International Journal of Cancer|February 9, 2005
Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitroClaudio Festuccia, Giovanni Luca Gravina, Adriano Angelucci, et al.
International Journal of Oncology|April 6, 2005
Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samplesClaudio Festuccia, Adriano Angelucci, Giovanni Luca Gravina, et al.
The Prostate|March 26, 2004
Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cellsAdriano Angelucci, Claudio Festuccia, Giovanni Luca Gravina, et al.
The Journal of Urology|May 24, 2008
Effects of dutasteride on prostate carcinoma primary cultures: a comparative study with finasteride and MK386Claudio Festuccia, Giovanni Luca Gravina, Paola Muzi, et al.
Bioorganic & Medicinal Chemistry Letters|January 31, 2009
Indolyl-pyrrolone as a new scaffold for Pim1 inhibitorsStefania Olla, Fabrizio Manetti, Emmanuele Crespan, et al.
BMC Cancer|November 6, 2010
Antiproliferative and pro-apoptotic effects afforded by novel Src-kinase inhibitors in human neuroblastoma cellsMichele Navarra, Marilena Celano, Jessica Maiuolo, et al.
Cancer Research|July 16, 2010
Receptor activator of NF-kappaB ligand enhances breast cancer-induced osteolytic lesions through upregulation of extracellular matrix metalloproteinase inducer/CD147Nadia Rucci, Danilo Millimaggi, Marianna Mari, et al.
European Journal of Cancer (Oxford, England : 1990)|September 16, 2006
Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cellsAdriano Angelucci, Silvia Schenone, Giovanni Luca Gravina, et al.
International Journal of Molecular Sciences|April 30, 2021
The Importance of Tumor Stem Cells in Glioblastoma Resistance to TherapyVincenzo Mattei, Francesca Santilli, Stefano Martellucci, et al.
BMC Cancer|March 7, 2014
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progressionPatrizia Sanità, Mattia Capulli, Anna Teti, et al.
Pageof 10

Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|February 9, 2005
Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitroClaudio Festuccia, Giovanni Luca Gravina, Adriano Angelucci, et al.
International Journal of Oncology|April 6, 2005
Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samplesClaudio Festuccia, Adriano Angelucci, Giovanni Luca Gravina, et al.
The Prostate|March 26, 2004
Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cellsAdriano Angelucci, Claudio Festuccia, Giovanni Luca Gravina, et al.
The Journal of Urology|May 24, 2008
Effects of dutasteride on prostate carcinoma primary cultures: a comparative study with finasteride and MK386Claudio Festuccia, Giovanni Luca Gravina, Paola Muzi, et al.
Bioorganic & Medicinal Chemistry Letters|January 31, 2009
Indolyl-pyrrolone as a new scaffold for Pim1 inhibitorsStefania Olla, Fabrizio Manetti, Emmanuele Crespan, et al.
BMC Cancer|November 6, 2010
Antiproliferative and pro-apoptotic effects afforded by novel Src-kinase inhibitors in human neuroblastoma cellsMichele Navarra, Marilena Celano, Jessica Maiuolo, et al.
Cancer Research|July 16, 2010
Receptor activator of NF-kappaB ligand enhances breast cancer-induced osteolytic lesions through upregulation of extracellular matrix metalloproteinase inducer/CD147Nadia Rucci, Danilo Millimaggi, Marianna Mari, et al.
European Journal of Cancer (Oxford, England : 1990)|September 16, 2006
Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cellsAdriano Angelucci, Silvia Schenone, Giovanni Luca Gravina, et al.
International Journal of Molecular Sciences|April 30, 2021
The Importance of Tumor Stem Cells in Glioblastoma Resistance to TherapyVincenzo Mattei, Francesca Santilli, Stefano Martellucci, et al.
BMC Cancer|March 7, 2014
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progressionPatrizia Sanità, Mattia Capulli, Anna Teti, et al.
Pageof 10